Ernexa Therapeutics Inc. Prepaid Expense and Other Assets
Ernexa Therapeutics Inc. (ERNA) had Prepaid Expense and Other Assets of $1.00 million as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2015-11-09
- 2015-09-30: Prepaid Expense and Other Assets $1.00M.
- 2015-06-30: Prepaid Expense and Other Assets $660.00K.
- 2015-03-31: Prepaid Expense and Other Assets $642.00K.
- 2014-12-31: Prepaid Expense and Other Assets $742.00K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2015-09-30 | $1.00M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $660.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $642.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $742.00K 10-Q · filed 2015-11-09 |
| 2014-09-30 | $4.65M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $3.41M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.94M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.82M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $1.19M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.14M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $914.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $898.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $832.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $565.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $587.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $624.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $506.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $535.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $588.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |